🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
HCC is an aggressive, largely chemo-resistant cancer with a poor prognosis,...
Status
Unknown
Location
Queen Mary Hospital
Start Date
2007-09
Trial ID
NCT00752063
Treatments Being Tested
This study involves the use of oxaliplatin, capecitabine, and sorafenib whi...
Status
Completed
Location
University of Wisconsin
Start Date
2008-02
Trial ID
NCT00634751
Treatments Being Tested
The purpose of the present study is to investigate the benefit of anti-canc...
Status
Completed
Location
Department of Oncology, Aalborg University Hospital
Start Date
2017-09-22
Trial ID
NCT03251612
Treatments Being Tested
The purpose of this study is to determine if sorafenib, capecitabine and ox...
Status
Completed
Location
Queen Mary Hospital
Start Date
2016-03
Trial ID
NCT02716766
Treatments Being Tested
The purpose of this study is to evaluate the resectability after treatment ...
Status
Completed
Location
Queen Mary Hospital
Start Date
2016-06-20
Trial ID
NCT03578874
Treatments Being Tested
The purpose of this study is to assess the feasibility of selecting persona...
Status
Completed
Location
Hospital Universitario de Fuenlabrada
Start Date
2012-11
Trial ID
NCT01703910
Treatments Being Tested
This phase Ib trial determines if samples from a patient's cancer can be te...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2020-04-01
Trial ID
NCT03878524
Treatments Being Tested